Organisation paid for research Program year 2021 Source: CMS Open Payments

Bayview Research Group, LLC

Neither a doctor nor a teaching hospital

Research payments

$459,998

304 payments

Through program year 2021, Bayview Research Group, LLC is reported as receiving $459,998 in research payments, across 304 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$13,077	2
2020	Research	$75,874	116
2019	Research	$371,046	186

Breakdown

Who paid Research payments · program years 2019–2021

Merck Sharp & Dohme Corporation $459,248 303 payments
Amgen Inc. $750 1 payment

Studies the money was for Research payments · program years 2019–2021

Double-Blind, Randomized, Placebo-Controlled Phase 2b, Multi-center Study to Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of a 2-Dose and a 3-Dose Regimen of V160 Cytomegalovirus CMV Vaccine in Healthy Seronegative Women, 16 to 35 Years of Age $279,218 25 payments
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When administered Concomitantly with Influenza Vaccine in Healthy Adults 50 Years of Age or Older PNEU -FLU $106,742 5 payments
A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 SCH 900931 in Subjects with Amnestic Mild Cognitive Impairment Due to Alzheimer s Disease Prodromal AD. $42,235 15 payments
Double-Blind, Randomized, Placebo-Controlled Phase 2b, Multi-center Study to Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of a 2-Dose and a 3-Dose Regimen of V160 Cytomegalovirus CMV Vaccine in Healthy Seronegative Women, 16 to 35 Years of Age $30,071 257 payments
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When administered Concomitantly with Influenza Vaccine in Healthy Adults 50 Years of Age or Older PNEU FLU $981 1 payment
FOURIER OLE (Ph 4) $750 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.